Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
Completed
GlaxoSmithKline
Phase 4
2004-12-01
Comparing the efficacy and safety of a gel formulation containing a combination of
clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily
with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to
moderate severity.
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
Completed
Stiefel, a GSK Company
Phase 4
2004-12-01
Comparing the efficacy and safety of a gel formulation containing a combination of
clindamycin phosphate (equivalent to 1% clindamycin) and benzoyl peroxide (5%) once daily
with a gel containing 0.1% adapalene once daily in the treatment of acne vulgaris of mild to
moderate severity.
Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Completed
GlaxoSmithKline
Phase 4
2006-11-01
The objectives of this clinical trial are to compare the quality of life of the subjects, the
efficacy and the tolerance of Duac® Gel (gel formulation with a combination of clindamycin
phosphate [equivalent to 1% clindamycin] and 5% benzoyl peroxide), applied once daily,
against Differin® Gel (gel with 0.1% adapalene), used once daily, in the treatment of mild to
moderate acne vulgaris.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
